Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Editing for Inherited Red Blood Cell Diseases. | Front Physiol | 2022 | 35418876 | PubTator, text mining | PubMed |
| The Impact of BCL11A Polymorphisms on Endometrial Cancer Risk Among Chinese Han Females. | Pharmgenomics Pers Med | 2022 | 35418772 | PubTator, text mining | PubMed |
| Mechanisms of resistance to targeted therapies for relapsed or refractory acute myeloid leukemia. | Exp Hematol | 2022 | 35417742 | PubTator, text mining | PubMed |
| Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint. | Molecules | 2022 | 35408561 | PubTator, text mining | PubMed |
| Proteomic Analysis of the Role of the Adenylyl Cyclase-cAMP Pathway in Red Blood Cell Mechanical Responses. | Cells | 2022 | 35406814 | PubTator, text mining | PubMed |
| Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial Insulinomatosis. | Cancers (Basel) | 2022 | 35406570 | PubTator, text mining | PubMed |
| Hepatitis C Virus Infection Cycle-Specific MicroRNA Profiling Reveals Stage-Specific miR-4423-3p Targets RIG-I to Facilitate Infection. | Front Cell Infect Microbiol | 2022 | 35402303 | PubTator, text mining | PubMed |
| Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery. | Nat Commun | 2022 | 35388006 | PubTator, text mining | PubMed |
| Developmental maturation of the hematopoietic system controlled by a Lin28b-let-7-Cbx2 axis. | Cell Rep | 2022 | 35385744 | PubTator, text mining | PubMed |
| Of mice and men: From hematopoiesis in mouse models to curative gene therapy for sickle cell disease. | Cell | 2022 | 35385685 | PubTator, text mining | PubMed |
| Plasma proteome profiling combined with clinical and genetic features reveals the pathophysiological characteristics of β-thalassemia. | iScience | 2022 | 35378860 | PubTator, text mining | PubMed |
| Association of tumor necrosis factor alpha -308 single nucleotide polymorphism with SARS CoV-2 infection in an Iraqi Kurdish population. | J Clin Lab Anal | 2022 | 35373411 | PubTator, text mining | PubMed |
| A landscape analysis and discussion of value of gene therapies for sickle cell disease. | Expert Rev Pharmacoecon Outcomes Res | 2022 | 35363602 | PubTator, text mining | PubMed |
| A Small-Molecule Cocktails-Based Strategy in Culture of Mesenchymal Stem Cells. | Front Bioeng Biotechnol | 2022 | 35360405 | PubTator, text mining | PubMed |
| The CCR5 Gene Edited CD34+CD90+ Hematopoietic Stem Cell Population Serves as an Optimal Graft Source for HIV Gene Therapy. | Front Immunol | 2022 | 35359982 | PubTator, text mining | PubMed |
| DNA methylation of Nuclear Factor of Activated T Cells 1 mediates the prospective relation between exposure to different traumatic event types and post-traumatic stress disorder. | Psychiatry Res | 2022 | 35349860 | PubTator, text mining | PubMed |
| COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity. | Immunogenetics | 2022 | 35348847 | PubTator, text mining | PubMed |
| Heterozygosity of the Complex Corfu δ0β+ Thalassemic Allele (HBD Deletion and HBB:c.92+5G>A) Revisited | Biology (Basel) | 2022 | 35336809 | PubTator, text mining | PubMed |
| Protein interaction networks provide insight into fetal origins of chronic obstructive pulmonary disease. | Respir Res | 2022 | 35331221 | PubTator, text mining | PubMed |
| Triiodothyronine (T3) Induces Limited Transcriptional and DNA Methylation Reprogramming in Human Monocytes. | Biomedicines | 2022 | 35327410 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=42